← Back to Patent Explorer
US3671518A Expired / Lapsed US ⏱️ 0.0 years remaining

Benzodiazepin-2-ones and processes for their preparation

Assignee: F Hoffmann La Roche AG
•
Filing: 1970-03-06
•
Granted: 1972-06-20
•
Expires: 1990-03-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 3-substituted benzodiazepin-2-ones, derivatives thereof and processes for their preparation are described. These compounds are useful as anti-convulsants, muscle relaxants and sedatives.

Inventors

  • 👤 Joseph Hellerbach
  • 👤 Andre Szente
  • 👤 Armin Walser

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 11:12
CPC Classifications
C; C07; C07D; C07D215/00; C07D215/02; C07D215/16; C07D215/48; C07D215/54; C07D215/56; C07C; C07C271/00; C07C271/06; C07C271/08; C07C271/10; C07C271/22; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 19 words
A compound of claim 1 wherein the R1 substituent is selected from the group consisting of chlorine or nitro.
Claim 2
Dependent Claim 20 words
A compound of claim 1 wherein the R2 substituent is selected from the group consisting of chlorine, fluorine or hydrogen.
Claim 3
Dependent Claim 11 words
A compound of claim 1 wherein the R3 substituent is hydrogen.
Claim 4
Dependent Claim 21 words
A compound of claim 1 wherein the R4 substituent is selected from the group consisting of hydrogen, methyl or methoxy methyl.
Claim 5
Dependent Claim 21 words
A compound of claim 1 wherein the X substituent is selected from the group consisting of ethylene, propylene or the group
Claim 6
Dependent Claim 21 words
A compound of claim 1 wherein the R5 and R6 substituents are each methyl, ethyl, or taken together a morpholino group.
Claim 7
Dependent Claim 31 words
The compound of claim 1 wherein R1 is chlorine, R2 and R3 are hydrogen, R4 is methyl, R5 and R6 are each ethyl and X is propyl, i.e. 3-diethylaminopropyl 7-chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3 -carboxylate.
Claim 8
Dependent Claim 30 words
The compound of claim 1 wherein R1 and R2 are chlorine, R3 and R4 are hydrogen, R5 and R6 are each ethyl and X is propyl, i.e. 3-diethylaminopropyl 7-chloro-2,3-dihydro-2-oxo-5-(2-chlorophenyl)-1H-1,4-benzodiazepine-3 -carboxylate.
Claim 9
Dependent Claim 27 words
The compound of claim 1 wherein R1 is chlorine, R2, R3 and R4 are hydrogen, R5 and R6 are methyl, and X is methylpropyl, i.e. 2-(dimethylamino)-2-methylpropyl 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate.
Claim 10
Dependent Claim 28 words
The compound of claim 1 wherein R1 is nitro, R2, R3 and R4 are hydrogen, R5 and R6 are each ethyl and X is propyl, i.e. 3-diethylaminopropyl 2,3-dihydro-7-nitro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate.
Claim 11
Dependent Claim 29 words
The compound of claim 1 wherein R1 is chlorine, R2, R3 and R4 are hydrogen, R5 and R6 taken together are morpholino and X is ethyl, i.e. 2-morpholinoethyl 7-chloro-5-phenyl-2,3-dihydro-2-oxo-1H-1,4-benzodiazepine-3-carboxylate.
Claim 12
Dependent Claim 33 words
The compound of claim 1 wherein R1 is nitro, R2 is chlorine, R3 is hydrogen, R4 is methyl, R5 and R6 taken together are morpholino, and X is propyl, i.e. 3-morpholinopropyl 7-nitro-5-(o-chlorophenyl)-2,3-dihydro-1-methyl-2-oxo-1H-1,4-benzodiazepine -3-carboxylate.
Claim 13
Dependent Claim 33 words
The compound of claim 1 wherein R1 is nitro, R2 is chlorine, R3 is hydrogen, R4 is methoxymethyl, R5 and R6 taken together are morpholino, and X is propyl, i.e. 3-morpholinopropyl 7-nitro-5-(o-chlorophenyl)-2,3-dihydro-1-methoxymethyl-2-oxo-1H-1,4 -benzodiazepine-3-carboxylate.
Claim 14
Dependent Claim 32 words
The compound of claim 1 wherein R1 is nitro, R2 is chlorine, R3 and R4 are hydrogen, R5 and R6 taken together are morpholino, and X is propyl, i.e. 3-morpholinopropyl 7-nitro-5-(o-chlorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepine-3 -carboxylate.
Claim 15
Dependent Claim 5 words
A compound of the formula

References Cited (Backward Citations)

US3371085A Cited
US3299053A Cited
US3516988A Cited
US3391138A Cited
US3475415A Cited
US3410844A Cited
US3450695A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1975-06-20 1975-12-20 1976-06-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1979-06-20 1979-12-20 1980-06-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1983-06-20 1983-12-20 1984-06-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag